263 related articles for article (PubMed ID: 25511190)
1. Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.
San-Miguel JF; Kantarjian HM
Nat Rev Clin Oncol; 2015 Feb; 12(2):71-2. PubMed ID: 25511190
[TBL] [Abstract][Full Text] [Related]
2. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
[No Abstract] [Full Text] [Related]
3. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
[No Abstract] [Full Text] [Related]
4. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
D'Arena G; Gemei M; Luciano L; D'Auria F; Deaglio S; Statuto T; Bianchino G; Grieco V; Mansueto G; Guariglia R; Pietrantuono G; Martorelli MC; Villani O; Del Vecchio L; Musto P
J Clin Oncol; 2012 Nov; 30(32):e327-30. PubMed ID: 23008321
[No Abstract] [Full Text] [Related]
5. Leukaemias into the 21st century. Part 2: the chronic leukaemias.
Gibson J; Iland HJ; Larsen SR; Brown CM; Joshua DE
Intern Med J; 2013 May; 43(5):484-94. PubMed ID: 23668266
[TBL] [Abstract][Full Text] [Related]
6. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
Ahn S; Park JS; Han JH; Cho SR
Ann Lab Med; 2015 May; 35(3):370-2. PubMed ID: 25932449
[No Abstract] [Full Text] [Related]
7. Quantitative Analysis of Red Bone Marrow Microenvironment Cells in Patients with Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphocytic Leukemia in the Dynamics of Chemotherapy.
Dolgikh TY; Kachesov IV; Tornuev VV; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2018 Oct; 165(6):786-789. PubMed ID: 30353331
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous occurrence of chronic lymphocytic and chronic myeloid leukemia.
Katović SK; Vasilj A; Maricević I; Carzavec D; Jurić SC
Coll Antropol; 2010 Jun; 34(2):653-5. PubMed ID: 20698147
[TBL] [Abstract][Full Text] [Related]
9. [Update on malignant hematologic diseases].
Marie JP; Delmer A
Bull Cancer; 1998 Jan; 85(1):42-4. PubMed ID: 9752345
[No Abstract] [Full Text] [Related]
10. Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.
Yoon JY; Kumar R; Aloyz R; Johnston JB
Leuk Res; 2011 Sep; 35(9):e179-80. PubMed ID: 21802141
[No Abstract] [Full Text] [Related]
11. Connection between Parameters of Erythron System and Myelofibrosis during Chronic Myeloleukemia, Multiply Mieloma, and Chronic Lymphatic Leukemia.
Dolgikh TY; Sholenberg EV; Kachesov IV; Senchukova SR
Bull Exp Biol Med; 2018 Jan; 164(3):382-385. PubMed ID: 29308562
[TBL] [Abstract][Full Text] [Related]
12. Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases.
Chen Z; Wang W; Rich A; Tang G; Hu S
Am J Hematol; 2015 Aug; 90(8):E146-8. PubMed ID: 25960187
[No Abstract] [Full Text] [Related]
13. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia.
Tecchio C; Nichele I; Todeschini G; Pizzolo G; Ambrosetti A
Br J Haematol; 2009 Jul; 146(2):222-3. PubMed ID: 19466973
[No Abstract] [Full Text] [Related]
14. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
15. A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Cheson BD; Ashforth E
Clin Adv Hematol Oncol; 2009 Sep; 7(9 Suppl 15):1-22; quiz 23-4. PubMed ID: 20102012
[No Abstract] [Full Text] [Related]
16. Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.
Guru Murthy GS; Sawyer J; Alapat D; Samant R; Barlogie B
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e127-9. PubMed ID: 24685577
[No Abstract] [Full Text] [Related]
17. Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions.
Dashputre AA; S Gatwood K; Schmidt J; Gatwood J
J Oncol Pharm Pract; 2020 Jun; 26(4):835-845. PubMed ID: 31575355
[TBL] [Abstract][Full Text] [Related]
18. The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma.
Hangül C; Yücel OK; Akkaya B; Ündar L; Berker Karaüzüm S
Turk J Haematol; 2019 May; 36(2):124-125. PubMed ID: 29923494
[No Abstract] [Full Text] [Related]
19. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
20. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
Ragupathi L; Najfeld V; Chari A; Petersen B; Jagannath S; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):175-9. PubMed ID: 23168212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
